<p>Hepion Pharmaceuticals, Inc. (HEPA) 周一表示，自 6 月 16 日起任命 Kaouthar Lbiati 为临时首席执行官，此前 John Brancaccio 决定因个人原因退休。</p>
<p>Lbiati 自 2022 年 6 月以来一直担任 Hepion 董事会成员，并在生物技术和大型制药公司拥有超过 15 年的领导经验。</p>
<p>如需评论和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

HEPA

<p>Hepion Pharmaceuticals 已任命 Kaouthar Lbiati 为临时首席执行官，任命自 6 月 16 日生效，此前首席执行官 John Brancaccio 因个人原因退休。Lbiati 自 2022 年 6 月以来一直担任董事会成员，拥有超过 15 年的生物技术和大型制药公司的领导经验</p>

<p>Hepion Pharmaceuticals, Inc. (HEPA) said on Monday that it has appointed Kaouthar Lbiati as interim Chief Executive Officer with effect from June 16 after John Brancaccio decided to retire for personal reasons.</p>
<div class="lb-trans"><p>Hepion Pharmaceuticals, Inc. (HEPA) 周一表示，自 6 月 16 日起任命 Kaouthar Lbiati 为临时首席执行官，此前 John Brancaccio 决定因个人原因退休。</p>
</div><p>Lbiati has been serving as a member of Hepion's Board since June 2022 and has over 15 years of leadership experience in both biotech and large pharmaceutical companies.</p>
<div class="lb-trans"><p>Lbiati 自 2022 年 6 月以来一直担任 Hepion 董事会成员，并在生物技术和大型制药公司拥有超过 15 年的领导经验。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如需评论和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Hepion Pharmaceuticals 任命 Kaouthar Lbiati 为临时 CEO